These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11586885)

  • 1. Monitoring activation of ribonuclease L by 2',5'-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells.
    Rusch L; Dong B; Silverman RH
    Methods Enzymol; 2001; 342():10-20. PubMed ID: 11586885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.
    Yoshimura A; Nakanishi M; Yatome C; Kitade Y
    J Biochem; 2002 Oct; 132(4):643-8. PubMed ID: 12359081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta.
    Rusch L; Zhou A; Silverman RH
    J Interferon Cytokine Res; 2000 Dec; 20(12):1091-100. PubMed ID: 11152576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
    Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
    Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of oligoribonucleotides by the 2',5'-oligoadenylate- dependent ribonuclease L.
    Carroll SS; Chen E; Viscount T; Geib J; Sardana MK; Gehman J; Kuo LC
    J Biol Chem; 1996 Mar; 271(9):4988-92. PubMed ID: 8617774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNase L dimerization in a mammalian two-hybrid system in response to 2',5'-oligoadenylates.
    Naik S; Paranjape JM; Silverman RH
    Nucleic Acids Res; 1998 Mar; 26(6):1522-7. PubMed ID: 9490801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stoichiometry of 2',5'-oligoadenylate-induced dimerization of ribonuclease L. A sedimentation equilibrium study.
    Cole JL; Carroll SS; Kuo LC
    J Biol Chem; 1996 Feb; 271(8):3979-81. PubMed ID: 8626728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling gene expression with 2-5A antisense.
    Leaman DW; Cramer H
    Methods; 1999 Jul; 18(3):252-65. PubMed ID: 10454983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-5A-dependent RNase molecules dimerize during activation by 2-5A.
    Dong B; Silverman RH
    J Biol Chem; 1995 Feb; 270(8):4133-7. PubMed ID: 7876164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
    Bayard B; Bisbal C; Lebleu B
    Biochemistry; 1986 Jun; 25(12):3730-6. PubMed ID: 3013297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L.
    Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF
    Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2',5'-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits.
    Salehzada T; Silhol M; Steff AM; Lebleu B; Bisbal C
    J Biol Chem; 1993 Apr; 268(11):7733-40. PubMed ID: 8463302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of RNase L by 2',5'-oligoadenylates. Biophysical characterization.
    Cole JL; Carroll SS; Blue ES; Viscount T; Kuo LC
    J Biol Chem; 1997 Aug; 272(31):19187-92. PubMed ID: 9235909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorothioate analogues of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates.
    Karikó K; Li SW; Sobol RW; Suhadolnik RJ; Charubala R; Pfleiderer W
    Biochemistry; 1987 Nov; 26(22):7136-42. PubMed ID: 3427063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
    Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
    ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
    [No Abstract]   [Full Text] [Related]  

  • 17. n-Decyl-NHpppA2'p5'A2'p5'A A phosphatase-resistant, active pppA2'p5'A2'p5'A analog.
    Karikó K; Ludwig J
    Biochem Biophys Res Commun; 1985 Apr; 128(2):695-8. PubMed ID: 2581566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
    Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
    Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of analogs of 2-5A determined using the core-cellulose assay for 2-5A-dependent RNase.
    Krause D; Lesiak K; Imai J; Sawai H; Torrence PF; Silverman RH
    Prog Clin Biol Res; 1985; 202():133-9. PubMed ID: 3832069
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
    Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.